You are here: Home » Current Affairs » Coronavirus » News
Business Standard

AstraZeneca expands Covid-19 vaccine supply tie-up with Oxford Biomedica

AstraZeneca has expanded its agreement with Oxford Biomedica to make and supply the drugmaker's COVID-19 vaccine candidate

Topics
Coronavirus | Coronavirus Vaccine | Oxford University

Reuters 

(Reuters) - AstraZeneca has expanded its agreement with Oxford Biomedica to make and supply the drugmaker's COVID-19 vaccine candidate, in a deal that will pay the gene and cell therapy firm 15 million pounds ($20 million) upfront and an additional 35 million pounds plus other costs by the end of 2021. Oxford Biomedica said in a statement that under the deal it would mass-produce the potential vaccine, AZD1222, for the novel coronavirus for a period of 18 months, which may be further extended by another 18 months into 2022 and 2023.     ($1 = 0.7458 ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Tue, September 01 2020. 14:17 IST
RECOMMENDED FOR YOU